M K Proteins Limited — Outcome of Board Meeting

M K Proteins Limited has informed exchanges that its board has approved the release of un-audited standalone financial results for the quarter and half-year ended September 30, 2026. The company has also submitted its statement of cash flow and the statement of assets and liabilities for the same period.

This disclosure is a routine regulatory requirement that signals the company's readiness to share its interim financial performance with the market. For investors, these documents provide an early window into the company's operational health, liquidity position, and financial stability before the official audit is completed.

Investors should monitor the upcoming filings for key metrics such as revenue growth, net profit margins, and cash flow generation. This data will offer a clearer picture of the company's current trajectory and help assess its performance against market expectations.